Amidst unprecedented company changes, Johnson & Johnson (J&J) unveiled quarterly results on Tuesday that exceeded Wall Street’s anticipations. Following its separation from the consumer health spinoff Kenvue in August—a monumental move in J&J’s 137-year history—the company has witnessed significant surges in its pharmaceutical and medical devices sales. After the August split, the pharmaceutical powerhouse initially…